Article Link: FDA Approves Vizimpro (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer
...

Article Link: FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma �...

Article Link: FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine September 14, 2018 — Today, the US Food a...

Article Link: FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension MUMBAI, India &a...

Article Link: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA) South San ...

Article Link: FDA Approves Lumoxiti (moxetumomab pasudotox-tdfk) for Hairy Cell Leukemia September 13, 2018 — The U.S. Food and Dru...

Article Link: FDA Approves Cassipa (buprenorphine and naloxone) Sublingual Film as Maintenance Treatment for Opioid Dependence September ...

Article Link: ITF Pharma Announces FDA Approval of Tiglutik (riluzole) Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis (ALS) ...

Article Link: FDA Approves Merck’s Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Appropriate Patients&...

Article Link: FDA Approves Merck’s Pifeltro (doravirine) for the Treatment of HIV-1 in Appropriate Patients KENILWORTH, N.J.–(BUSIN...